FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106007 [Registered on: 12/03/2026] Trial Registered Prospectively
Last Modified On: 12/03/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   “A Study Comparing two materials ( Biodentin and Human Amniotic Membrane)for Treating Infected Developing Back Teeth in Children.” 
Scientific Title of Study   Comparative Evaluation of Clinical and Radiographic Outcomes between Biodentin and Human Amniotic Membrane in Pulpotomy of developing Mandibular Second Molars with Irreversible Pulpitis: A Randomised Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR VARNA R 
Designation  ASSISTANT PROFESSOR 
Affiliation  Govt Dental College, Kozhikode 
Address  Room no 63, Dept of conservative dentistry and endodontics, govt dental college, Kozhikode
Plot 28, HARINANDANAM, MEDICAL COLLEGE HOUSING BOARD COLONY, KOZHIKODE
Kozhikode
KERALA
673008
India 
Phone  9895673748  
Fax    
Email  varnarajesh25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR VARNA R 
Designation  ASSISTANT PROFESSOR 
Affiliation  Govt Dental College, Kozhikode 
Address  Room no 63, Dept of conservative dentistry and endodontics, govt dental college, Kozhikode
Plot 28, HARINANDANAM, MEDICAL COLLEGE HOUSING BOARD COLONY, KOZHIKODE

KERALA
673008
India 
Phone  9895673748  
Fax    
Email  varnarajesh25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR VARNA R 
Designation  ASSISTANT PROFESSOR 
Affiliation  Govt Dental College, Kozhikode 
Address  Room no 63, Dept of conservative dentistry and endodontics, govt dental college, Kozhikode
Plot 28, HARINANDANAM, MEDICAL COLLEGE HOUSING BOARD COLONY, KOZHIKODE

KERALA
673008
India 
Phone  9895673748  
Fax    
Email  varnarajesh25@gmail.com  
 
Source of Monetary or Material Support  
Govt. DENTAL COLLEGE, KOZHIKODE, KERALA, INDIA 
 
Primary Sponsor  
Name  DR VARNA R 
Address  ASSISTANT PROFESSOR,ROOM NO 63, DEPT OF CONSERVATIVE DENTISTRY, GOVT DENTAL COLLEGE , KOZHIKODE, KERALA , INDIA PIN 673008 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR VARNA R  GOVT DENTAL COLLEGE, KOZHIKODE  Room no 63, DEPT OF CONSDRVATIVE DENTISTRY AND ENDODONTICS, KOZHIKODE, KERLA, INDIA. PIN 673008
Kozhikode
KERALA 
9895673748

varnarajesh25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, GDC, KOZHIKODE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K00-K95||Diseases of the digestive system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Biodentin Pulpotomy  Pulpotomy will be performed under local anesthesia and rubber dam isolation. After access opening and coronal pulp amputation, hemostasis will be achieved using sterile saline-moistened cotton pellets. Biodentin (Septodont, France) will be mixed according to the manufacturer’s instructions and placed over the radicular pulp stumps. A base of glass ionomer cement will be placed over Biodentin, followed by permanent restoration. Clinical and radiographic evaluation will be performed at 1, 3, and 6 months. 
Intervention  Human Amniotic Membrane Pulpotomy  Pulpotomy will be performed under local anesthesia and rubber dam isolation. Following access opening and removal of coronal pulp tissue, hemostasis will be achieved with sterile saline-moistened cotton pellets. Sterile processed Human Amniotic Membrane will be trimmed to appropriate size and placed directly over the radicular pulp stumps. A base of glass ionomer cement will be placed, followed by permanent restoration. Clinical and radiographic follow-up will be conducted at 1, 3, and 6 months. 
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  17.00 Year(s)
Gender  Both 
Details  Participants will include healthy children aged 13–17 years (ASA I/II) with developing permanent second molars showing incomplete root formation and a vital pulp diagnosis suitable for pulpotomy. Teeth must have restorable crowns, no radiographic evidence of periapical or furcal radiolucency, no internal/external resorption, and the radicular pulp must exhibit controlled bleeding within 5 minutes after coronal pulp removal. Only teeth with adequate radiographic visibility and patients/guardians who provide informed consent and are willing to attend follow-up visits will be included.

 
 
ExclusionCriteria 
Details  Teeth will be excluded if they show signs of necrosis, uncontrolled radicular bleeding, irreversible pulpitis with swelling or sinus tract, internal or external resorption, or established periapical pathology. Patients with systemic diseases affecting healing (ASA III/IV), allergies to study materials, inability to return for follow-up, poor cooperation, recent antibiotic/steroid use that may confound outcomes, or teeth with previous pulpal procedures will be excluded. Teeth deemed unrestorable or compromised due to trauma, periodontal disease, or insufficient coronal structure will also be excluded.

 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Clinical Success of Pulpotomy
Absence of spontaneous pain
No swelling/sinus tract
• Positive vitality tests
 
base line, 1 month, 3 months, 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Radiographic Success
Dentin bridge formation
No periapical/furcal pathology
Continued root development/apical closure
 
base line, 1 month, 3 months, 6 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized controlled clinical trial aims to comparatively evaluate the clinical and radiographic outcomes of Biodentin and Human Amniotic Membrane when used as pulpotomy agents in developing permanent mandibular second molars diagnosed with irreversible pulpitis.

Eligible participants will be randomly allocated into two parallel groups in a 1:1 ratio. In Group I, pulpotomy will be performed using Biodentin as the pulp dressing material. In Group II, Human Amniotic Membrane will be placed over the radicular pulp tissue. All procedures will be carried out under standardized clinical protocols.

Participants will be evaluated clinically and radiographically at baseline, 1 month, 3 months, and 6 months. The primary outcome will be clinical and radiographic success at 6 months, defined as absence of pain, swelling, sinus tract, tenderness on percussion, abnormal mobility, and absence of radiographic signs such as periapical or furcal radiolucency, root resorption, or periodontal ligament widening.

The study aims to determine whether Human Amniotic Membrane demonstrates comparable clinical and radiographic success to Biodentin in pulpotomy procedures.

 
Close